GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Selvita SA (WAR:SLV) » Definitions » ROCE %

Selvita (WAR:SLV) ROCE % : 49.64% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Selvita ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Selvita's annualized ROCE % for the quarter that ended in Dec. 2023 was 49.64%.


Selvita ROCE % Historical Data

The historical data trend for Selvita's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Selvita ROCE % Chart

Selvita Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial Premium Member Only - 15.45 9.11 9.56 15.70

Selvita Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.19 3.79 9.92 3.43 49.64

Selvita ROCE % Calculation

Selvita's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=78.887/( ( (584.911 - 122.667) + (636.26 - 93.769) )/ 2 )
=78.887/( (462.244+542.491)/ 2 )
=78.887/502.3675
=15.70 %

Selvita's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=259.096/( ( (594.724 - 93.353) + (636.26 - 93.769) )/ 2 )
=259.096/( ( 501.371 + 542.491 )/ 2 )
=259.096/521.931
=49.64 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Selvita  (WAR:SLV) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Selvita ROCE % Related Terms

Thank you for viewing the detailed overview of Selvita's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Selvita (WAR:SLV) Business Description

Traded in Other Exchanges
N/A
Address
Bobrzynskiego 14, Park Life Science, Krakow, POL, 30-348
Selvita SA is a Poland based parent company of Selvita Group is one of the largest preclinical contract research organizations in Europe. It also develops bioinformatics solutions supporting innovative projects at preclinical stages. It also provides services provided to external contractors are in the field of chemistry, analytics, regulatory, biochemistry and cell biology and also the integrated research and development projects.

Selvita (WAR:SLV) Headlines

From GuruFocus

Paloma Partners Management Co Buys 3, Sells 2 in 4th Quarter

By GuruFocus Research GuruFocus Editor 02-18-2023

Caxton Associates Trims Apple, PayPal Positions

By Tiziano Frateschi Tiziano Frateschi 11-30-2020